Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-acetylornithine carbamoyltransferase (AOTC, EC 2.1.3.9) is an enzyme found in several eubacteria that catalyzes the transfer of a carbamoyl group from carbamoyl phosphate to N(2)-acetyl-L-ornithine, resulting in the formation of N-acetyl-L-citrulline and phosphate[1][2][4][6]. It is part of an alternative arginine biosynthesis pathway that substitutes for ornithine carbamoyltransferase (EC 2.1.3.3) in specific bacterial species and displays no catalytic activity toward L-ornithine[4][7]. The enzyme's activity and unique substrate specificity make it a potential antimicrobial target, especially as it defines a different arginine biosynthetic route compared to canonical pathways in most organisms[3][5][7]. Currently, no well-characterized drugs interact with this target, but inhibitors such as N-acetyl derivatives and related compounds have been used experimentally to study its function and mechanisms[5].
Enzyme inhibition (possible mechanism: blocking arginine biosynthesis in microbes by inhibiting AOTC) Substrate competition (in experimental contexts)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-acetylornithine carbamoyltransferase (AOTC).